英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
exegete查看 exegete 在百度字典中的解释百度英翻中〔查看〕
exegete查看 exegete 在Google字典中的解释Google英翻中〔查看〕
exegete查看 exegete 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home Main Testimonial – Synaptogenix
    Home Main Testimonial – Synaptogenix Home Main Testimonial – Synaptogenix
  • Team – Synaptogenix
    Test paragraph Charles Ryan
  • ApolipoproteinE3(ApoE3)butNotApoE4Protectsagainst . . . - Synaptogen
    Synaptic loss is the earliest pathological change in Alzheimer disease (AD) and is the pathological change most directly corre-lated with the degree of dementia ApoE4 is the major genetic risk factor for the age-dependent form of AD, which accounts for 95% of cases Here we show that in synaptic networks formed from primary hippocampal neurons in culture, apoE3, but not apoE4, prevents the
  • ApoE4 and A Oligomers Reduce BDNF Expression via HDAC . . . - Synaptogen
    ApoE4 and A Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation Abhik Sen, Thomas J Nelson, and Daniel L Alkon
  • Evidence of Significant Cognitive Improvement Over . . . - Synaptogen
    Results: Bryostatin Treatment (at Week #13) in the 1sttrial improved Severe Impairment Battery (SIB) scores over baseline (+4 5 over baseline, p< 04, 2-tailed, pre-specified exploratory analyses of AD patients, MMSE 14 – 4, vs placebo, without chronic Namenda, Farlow et al , J Alz Dis , 2019) In a second pilot trial, Bryostatin caused significant SIB improvement (+4 12 over baseline) in
  • Comments on: Fixed Left - synaptogen. com
    Comments on: Fixed Left Comments on: Fixed Left
  • Rebuilding Connections, Restoring Lives - Synaptogen
    FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995 All statements, other than statements of historical facts, included in this presentation regarding strategy, future operations, future financial position, future
  • PKC activator therapeutic for mild traumatic brain injury . . . - Synaptogen
    PKC activator therapeutic for mild traumatic brain injury in mice Ofer Zohar a, ⁎, Rotem Lavy a, Xiaomei Zi a, Thomas J Nelson a, Jarin Hongpaisan a, Chaim G Pick b, D L Alkon a
  • Pharmacology of protein kinase C activators: Cognition . . . - Synaptogen
    – threoninekinases PKCis central to many signaltransduction pathways It is ubiquitously and densely expressed in the brain (Saito et al , 1988) and activated by Ca2+, phospholipids and diacylglycerol, phorbolesters or other PKC activators Activation of PKC isozymes leads to phosphor-ylation of a variety of target proteins, depending on the cell types and isoformsinvolved
  • Towards universal therapeutics for memory disorders - Synaptogen
    Apolipoprotein E (ApoE) is a critical signal for synaptogen-esis and synaptic maturation [101] ApoE cholesterol com-plex released from astrocytes is taken up through low-density lipoprotein receptor-related protein 1 (LRP1) and activates PKCe synthesis in neurons [102], thereby acti-vating PKC-dependent neuronal repair pathways





中文字典-英文字典  2005-2009